165 related articles for article (PubMed ID: 33920565)
1. FDG-PET/CT and Para-Aortic Staging in Endometrial Cancer. A French Multicentric Study.
Sallée C; Margueritte F; Gouy S; Tardieu A; Belghiti J; Lambaudie E; Collinet P; Guyon F; Legros M; Monteil J; Gauthier T
J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33920565
[TBL] [Abstract][Full Text] [Related]
2. Para-aortic Lymph Node Invasion in High-risk Endometrial Cancer: Performance of
Legros M; Margueritte F; Tardieu A; Deluche E; Mbou VB; Lacorre A; Ceuca A; Aubard Y; Monteil J; Sallee C; Gauthier T
Anticancer Res; 2019 Feb; 39(2):619-625. PubMed ID: 30711937
[TBL] [Abstract][Full Text] [Related]
3. The Accuracy of Integrated [(18)F] Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Detection of Pelvic and Para-aortic Nodal Metastasis in Patients with High Risk Endometrial Cancer.
Gholkar NS; Saha SC; Prasad G; Bhattacharya A; Srinivasan R; Suri V
World J Nucl Med; 2014 Sep; 13(3):170-7. PubMed ID: 25538488
[TBL] [Abstract][Full Text] [Related]
4. Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer.
Kim HJ; Cho A; Yun M; Kim YT; Kang WJ
Ann Nucl Med; 2016 Feb; 30(2):104-13. PubMed ID: 26546334
[TBL] [Abstract][Full Text] [Related]
5. The Value of Preoperative Positron Emission Tomography/Computed Tomography in Node-Negative Endometrial Cancer on Magnetic Resonance Imaging.
Park JY; Lee JJ; Choi HJ; Song IH; Sung CO; Kim HO; Chae SY; Kim YT; Nam JH
Ann Surg Oncol; 2017 Aug; 24(8):2303-2310. PubMed ID: 28550488
[TBL] [Abstract][Full Text] [Related]
6. Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer.
Horowitz NS; Dehdashti F; Herzog TJ; Rader JS; Powell MA; Gibb RK; Grigsby PW; Siegel BA; Mutch DG
Gynecol Oncol; 2004 Dec; 95(3):546-51. PubMed ID: 15581961
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of preoperative
Hu J; Zhang K; Yan Y; Zang Y; Wang Y; Xue F
Arch Gynecol Obstet; 2019 Sep; 300(3):519-529. PubMed ID: 31165242
[TBL] [Abstract][Full Text] [Related]
8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of 18-fluoro-2-deoxy-D-glucose positron emission tomography in the pretherapeutic detection of occult para-aortic node involvement in patients with a locally advanced cervical carcinoma.
Leblanc E; Gauthier H; Querleu D; Ferron G; Zerdoud S; Morice P; Uzan C; Lumbroso S; Lecuru F; Bats AS; Ghazzar N; Bannier M; Houvenaeghel G; Brenot-Rossi I; Narducci F
Ann Surg Oncol; 2011 Aug; 18(8):2302-9. PubMed ID: 21347790
[TBL] [Abstract][Full Text] [Related]
10. A novel preoperative scoring system based on 18-FDG PET-CT for predicting lymph node metastases in patients with high-risk endometrial cancer.
Aşıcıoğlu O; Gungorduk K; Ozdemir A; Güngördük Ö; Gokçü M; Yaşar L; Sancı M
J Obstet Gynaecol; 2019 Jan; 39(1):105-109. PubMed ID: 30187784
[TBL] [Abstract][Full Text] [Related]
11. Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients.
Husby JA; Reitan BC; Biermann M; Trovik J; Bjørge L; Magnussen IJ; Salvesen ØO; Salvesen HB; Haldorsen IS
J Nucl Med; 2015 Aug; 56(8):1191-8. PubMed ID: 26045311
[TBL] [Abstract][Full Text] [Related]
12. Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT.
Crivellaro C; Signorelli M; Guerra L; De Ponti E; Pirovano C; Fruscio R; Elisei F; Montanelli L; Buda A; Messa C
Gynecol Oncol; 2013 Aug; 130(2):306-11. PubMed ID: 23707673
[TBL] [Abstract][Full Text] [Related]
13. [The accuracy of FDG-PET/CT in early-stage cervical and vaginal cancers].
Bentivegna E; Uzan C; Gouy S; Leboulleux S; Duvillard P; Lumbroso J; Haie-Meder C; Morice P
Gynecol Obstet Fertil; 2011 Apr; 39(4):193-7. PubMed ID: 21429783
[TBL] [Abstract][Full Text] [Related]
14. Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: detection of pelvic nodal metastases.
Signorelli M; Guerra L; Buda A; Picchio M; Mangili G; Dell'Anna T; Sironi S; Messa C
Gynecol Oncol; 2009 Nov; 115(2):231-5. PubMed ID: 19695685
[TBL] [Abstract][Full Text] [Related]
15.
Mayoral M; Paredes P; Domènech B; Fusté P; Vidal-Sicart S; Tapias A; Torné A; Pahisa J; Ordi J; Pons F; Lomeña F
Rev Esp Med Nucl Imagen Mol; 2017; 36(1):20-26. PubMed ID: 27667001
[TBL] [Abstract][Full Text] [Related]
16. [
Adam JA; van Diepen PR; Mom CH; Stoker J; van Eck-Smit BLF; Bipat S
Gynecol Oncol; 2020 Nov; 159(2):588-596. PubMed ID: 32921477
[TBL] [Abstract][Full Text] [Related]
17. FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer.
Swinnen G; Maes A; Pottel H; Vanneste A; Billiet I; Lesage K; Werbrouck P
Eur Urol; 2010 Apr; 57(4):641-7. PubMed ID: 19477579
[TBL] [Abstract][Full Text] [Related]
18. Preoperative 18F-FDG PET/CT tumor markers outperform MRI-based markers for the prediction of lymph node metastases in primary endometrial cancer.
Fasmer KE; Gulati A; Dybvik JA; Ytre-Hauge S; Salvesen Ø; Trovik J; Krakstad C; Haldorsen IS
Eur Radiol; 2020 May; 30(5):2443-2453. PubMed ID: 32034487
[TBL] [Abstract][Full Text] [Related]
19. Preoperative PET/CT does not accurately detect extrauterine disease in patients with newly diagnosed high-risk endometrial cancer: A prospective study.
Stewart KI; Chasen B; Erwin W; Fleming N; Westin SN; Dioun S; Frumovitz M; Ramirez PT; Lu KH; Wong F; Aloia TA; Soliman PT
Cancer; 2019 Oct; 125(19):3347-3353. PubMed ID: 31225906
[TBL] [Abstract][Full Text] [Related]
20. High-grade endometrial cancer: value of [(18)F]FDG PET/CT in preoperative staging.
Picchio M; Mangili G; Samanes Gajate AM; De Marzi P; Spinapolice EG; Mapelli P; Giovacchini G; Sigismondi C; Viganò R; Sironi S; Messa C
Nucl Med Commun; 2010 Jun; 31(6):506-12. PubMed ID: 20168262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
